Peer-reviewedLicence not statedEuropean Journal of Medicinal Chemistry
Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors
Related
- Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions
- Catamers: Multi-specific therapeutics that concatenate individual warheads on a DNA scaffold via Watson-Crick interactions
- Transglutaminase 3 is a Histone Monoaminylation Writer
- Immobilization of Microbial Transglutaminase for the Production of Homogeneous Immunotherapeutic Antibody-Drug Conjugates.
- Recent advances in scaffold-based KRASG12C inhibitors: SAR and biological evaluation insights
BibTeX
@article{badarau2026imidazoliumbased,
title = {{Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors}},
author = {Eduard Badarau and Alexandre Mongeot and Russell Collighan and Dan Rathbone and Martin Griffin},
journal = {European Journal of Medicinal Chemistry},
year = {2026},
month = oct,
doi = {10.1016/j.ejmech.2013.05.018},
url = {https://hal.science/hal-05793303v1},
}
RIS
TY - JOUR
TI - Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors
AU - Eduard Badarau
AU - Alexandre Mongeot
AU - Russell Collighan
AU - Dan Rathbone
AU - Martin Griffin
PY - 2026
DA - 2026/10/12
JO - European Journal of Medicinal Chemistry
DO - 10.1016/j.ejmech.2013.05.018
UR - https://hal.science/hal-05793303v1
SN - 0223-5234
SN - 1768-3254
ER -